A Roadmap to ALS Prevention: Strategies and Priorities

Overview

Journal J Neurol Neurosurg Psychiatry

Publisher BMJ Publishing Group

Specialties Neurology
Neurosurgery
Psychiatry

Date 2023 Jan 23

PMID 36690429

Authors

Michael Benatar

Stephen A Goutman

Kim A Staats

Eva L Feldman

Marc Weisskopf

Evelyn Talbott

Kuldip D Dave

Neil M Thakur

Ammar Al-Chalabi

Affiliations

Soon will be listed here.

Citing Articles

Improving prediction models of amyotrophic lateral sclerosis (ALS) using polygenic, pre-existing conditions, and survey-based risk scores in the UK Biobank.

Jin W, Boss J, Bakulski K, Goutman S, Feldman E, Fritsche L J Neurol. 2024; 271(10):6923-6934.

PMID: 39249108 DOI: 10.1007/s00415-024-12644-2.

Nanoplastics and Neurodegeneration in ALS.

Eisen A, Pioro E, Goutman S, Kiernan M Brain Sci. 2024; 14(5).

PMID: 38790450 PMC: 11119293. DOI: 10.3390/brainsci14050471.

Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohort.

Goutman S, Boss J, Jang D, Mukherjee B, Richardson R, Batterman S J Neurol Neurosurg Psychiatry. 2023; 95(3):241-248.

PMID: 37758454 PMC: 11060633. DOI: 10.1136/jnnp-2023-332121.

The amyotrophic lateral sclerosis exposome: recent advances and future directions.

Goutman S, Savelieff M, Jang D, Hur J, Feldman E Nat Rev Neurol. 2023; 19(10):617-634.

PMID: 37709948 PMC: 11027963. DOI: 10.1038/s41582-023-00867-2.

Presymptomatic amyotrophic lateral sclerosis: from characterization to prevention.

Benatar M, Turner M, Wuu J Curr Opin Neurol. 2023; 36(4):360-364.

PMID: 37382103 PMC: 10524989. DOI: 10.1097/WCO.0000000000001168.

References

Horner R, Kamins K, Feussner J, Grambow S, Hoff-Lindquist J, Harati Y . Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003; 61(6):742-9. DOI: 10.1212/01.wnl.0000069922.32557.ca. View

Al-Chalabi A, Hardiman O . The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013; 9(11):617-28. DOI: 10.1038/nrneurol.2013.203. View

Garton F, Trabjerg B, Wray N, Agerbo E . Cardiovascular disease, psychiatric diagnosis and sex differences in the multistep hypothesis of amyotrophic lateral sclerosis. Eur J Neurol. 2020; 28(2):421-429. DOI: 10.1111/ene.14554. View

Benatar M, Wuu J . Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology. 2012; 79(16):1732-9. PMC: 3468777. DOI: 10.1212/WNL.0b013e31826e9b1d. View

Chio A, Mazzini L, DAlfonso S, Corrado L, Canosa A, Moglia C . The multistep hypothesis of ALS revisited: The role of genetic mutations. Neurology. 2018; 91(7):e635-e642. PMC: 6105040. DOI: 10.1212/WNL.0000000000005996. View

Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis C, Hardiman O . Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 2014; 13(11):1108-1113. PMC: 4197338. DOI: 10.1016/S1474-4422(14)70219-4. View

Chuquilin M, Wymer S, Wymer J . Increasing Evidence for an Association Between Amyotrophic Lateral Sclerosis and Psychiatric Disorders. JAMA Neurol. 2017; 74(12):1396-1398. DOI: 10.1001/jamaneurol.2017.1920. View

Sagiraju H, Zivkovic S, VanCott A, Patwa H, de Porras D, Amuan M . Amyotrophic Lateral Sclerosis Among Veterans Deployed in Support of Post-9/11 U.S. Conflicts. Mil Med. 2019; 185(3-4):e501-e509. PMC: 8921606. DOI: 10.1093/milmed/usz350. View

Bedlack R, Vaughan T, Wicks P, Heywood J, Sinani E, Selsov R . How common are ALS plateaus and reversals?. Neurology. 2015; 86(9):808-12. PMC: 4793781. DOI: 10.1212/WNL.0000000000002251. View

10.

Miller T, Cudkowicz M, Shaw P, Andersen P, Atassi N, Bucelli R . Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for ALS. N Engl J Med. 2020; 383(2):109-119. DOI: 10.1056/NEJMoa2003715. View

11.

de Carvalho M, Swash M . The onset of ALS?. Clin Neurophysiol. 2010; 121(10):1709-10. DOI: 10.1016/j.clinph.2010.03.002. View

12.

Harrison D, Mehta P, van Es M, Stommel E, Drory V, Nefussy B . "ALS reversals": demographics, disease characteristics, treatments, and co-morbidities. Amyotroph Lateral Scler Frontotemporal Degener. 2018; 19(7-8):495-499. DOI: 10.1080/21678421.2018.1457059. View

13.

Spencer P . Parkinsonism and motor neuron disorders: Lessons from Western Pacific ALS/PDC. J Neurol Sci. 2021; 433:120021. DOI: 10.1016/j.jns.2021.120021. View

14.

Benatar M, Granit V, Andersen P, Grignon A, McHutchison C, Cosentino S . Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity. Brain. 2022; 145(10):3500-3508. PMC: 9586537. DOI: 10.1093/brain/awac185. View

15.

Pfeiffer R, Mayer B, Kuncl R, Check D, Cahoon E, Rivera D . Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs. Amyotroph Lateral Scler Frontotemporal Degener. 2019; 21(3-4):235-245. PMC: 9930913. DOI: 10.1080/21678421.2019.1682613. View

16.

Ferrari R, Kapogiannis D, Huey E, Momeni P . FTD and ALS: a tale of two diseases. Curr Alzheimer Res. 2011; 8(3):273-94. PMC: 3801195. DOI: 10.2174/156720511795563700. View

17.

Benatar M, Wuu J, McHutchison C, Postuma R, Boeve B, Petersen R . Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases. Brain. 2021; 145(1):27-44. PMC: 8967095. DOI: 10.1093/brain/awab404. View

18.

Hanby M, Scott K, Scotton W, Wijesekera L, Mole T, Ellis C . The risk to relatives of patients with sporadic amyotrophic lateral sclerosis. Brain. 2011; 134(Pt 12):3454-7. PMC: 3235555. DOI: 10.1093/brain/awr248. View

19.

Beard J, Engel L, Richardson D, Gammon M, Baird C, Umbach D . Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis survival. PLoS One. 2017; 12(10):e0185751. PMC: 5634564. DOI: 10.1371/journal.pone.0185751. View

20.

Mohamed H, Gurrola T, Berman R, Collins M, Sariyer I, Nonnemacher M . Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy. Front Immunol. 2022; 12():816515. PMC: 8811197. DOI: 10.3389/fimmu.2021.816515. View